Tevogen Bio appoints three leaders to its board of directors

Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cell and gene therapies in oncology, neurology, and virology, is pleased to announce the appointment of three new members to its Board of Directors. The new members include Susan Podlogar, M.B.A., Jeffrey Feike, M.P.H., and Lindee Goh, Ph.D. These nationally prominent healthcare leaders join Tevogen’s Board, effective immediately, alongside existing board members, Curtis Patton, Ph.D., and CEO Ryan Saadi, M.D., M.P.H.

The Board of Directors provides direction and guidance to Tevogen’s Executive Committee on strategy, policy, governance, and the achievement of milestones in accordance with company’s mission. The Board is tasked with further strengthening Tevogen’s organizational readiness as the company pursues its bold growth strategy.

“Susan, Jeffery, and Lindee are wholly committed to our corporate culture of creativity, optimism, respect, and equality and our aspiration to be the very first biopharma company to achieve commercial success while ensuring patient affordability,” said Tevogen CEO Ryan Saadi, M.D., M.P.H. “These new members bring decades of experience across critical aspects of the healthcare industry and will be integral to expediting the company’s current and future research endeavors and strategic business decisions.”

New board member bios:

• Susan Podlogar is MetLife’s Chief Human Resources Officer. Susan champions a prepared workforce and organization for the future. She is focused on upskilling employees globally and has gained support for the Workforce of the Future Development Fund and accelerated an internal talent marketplace. She also has a proven commitment to realizing a purpose-driven, inclusive culture where employees are energized to make a difference. Internal programs and external commitments, such as the Catalyst CEO Champions for Change pledge, the UN Women Global Innovation Coalition for Change, and the One Mind at Work pledge, are key drivers of this work. Podlogar also serves on MetLife Foundation’s Board of Directors. She also is called upon to provide thought leadership on innovative HR practices to various governmental and educational institutions. Previously, Podlogar served as the Global Vice President of Human Resources for Johnson & Johnson (J&J). Podlogar earned her MBA from the University of South Florida, with concentrations in Finance and Management, and a bachelor’s degree from the University of Wisconsin-Parkside, with a double major in Labor and Industrial Relations and Business Administration.
• Jeffrey Feike is a public health servant-leader with 30+ years of experience as CEO of multiple hospitals. In his distinguished career he has overseen the development of hospitals, outpatient clinics, and EMS systems coupled with a wide array of medical programs including Cancer Centers, Stroke Centers, and Trauma Centers. His hospitals have received national recognition from both the Joint Commission and the VHA for outstanding clinical excellence. He is past Chairman of the Nevada Hospital Association, and a 30-year member of the American College of Healthcare Executives. Feike holds an MPH from Tulane University graduating summa cum laude and has been inducted into the national public health honor society, Delta Omega.” He also serves as Tevogen’s Chief Patient Officer and is a member of the Innovation and Public Health Advisory Council (IPHAC).
• Lindee Goh leads Tapestry Networks’ healthcare practice, working with public and private sector leaders to develop effective strategies to improve clinical outcomes while fostering sustainable healthcare innovation. In doing this, she co-led several working groups, covering topics including the design and implementation of the parallel scientific advice process, approach to regulation and reimbursement in Europe, recommendations to address innovation, diagnostics, & infrastructure challenges of Alzheimer’s disease, molecular diagnostic quality assurance in precision medicine, healthcare financing and payment models in oncology and rare diseases, and multicancer early detection consortium. Before Tapestry Networks, Goh led teams at the Boston Consulting Group, working in biopharma, payer, and provider spaces. Goh holds a doctorate in biology and works as a Howard Hughes Medical Institute Fellow at the Center for Cancer Research at the Massachusetts Institute of Technology (MIT). She completed post-graduate work at MIT as a Leukemia and Lymphoma Fellow in neuroscience. She received her BS Honors in Biology from Caltech. Goh also serves as a member of Tevogen’s IPHAC.

Business Wire